Established in 2015, BioSense was founded to cater to the commercial requirements of the global biopharmaceutical industry, with a specific focus on China, Europe, and the United States. The organization's primary goal is to bridge the gap between underfunded biopharmaceutical projects, firms, and investors. BioSense's team of experienced biopharma executives and investors from around the world provide cross-cultural knowledge and advice while facilitating entry into new markets and securing additional resources and funding. BioSense is primarily involved in two sectors: Research and Development, and Investment.